AM-Pharma reports positive results from recAP Phase I trial for Acute Kidney ... News-Medical.net AM-Pharma B.V., a biopharmaceutical company focused on the development of recAP (recombinant human Alkaline Phosphatase) for inflammatory indications, announces the results of its Phase I trial with both single and multiple ascending doses, which ... AM-Pharma Announces Phase 1 AKI Drug Data |
